The contradictory results obtained after the inhibition of the CCR5/CCL5 on CD8 T cells and tumor progression might be due to the expression of this receptor/ligand on other cell types, such as immunosuppressive cells, and the proportion of these cells at the tumor site. This evidence concerns the gene CD8A and neoplasm.